Search Orphan Drug Designations and Approvals
-
Generic Name: | 2-{3-[(3R)-3-({[2-chloro-3-(trifluoromethyl)phenyl]methyl}(2,2-diphenylethyl)amino)butoxy]phenyl}acetic acid |
---|---|
Date Designated: | 06/16/2015 |
Orphan Designation: | Treatment of ovarian cancer. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Rgenix, Inc. 310 East 67th Street Suite 1-12 New York, New York 10065 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-